Activity value 72india Supplier,Last transaction date:
2025-09-24
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for medihome pharma from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 3 transactions, with a transaction quantity of 261 and a transaction weight of 0.
YearTransactionsQuantityWeight
202433910
202532610
Bill of lading data
<
1/15
>
Trade date
2025/09/24
B/L No.
6710768
Suppliers
medihome pharma
Buyers
svetlana rilkoff marco pol
4k collins
canadabuyer,they trade on 2021-10-28
25.00%
>
5james kassouf
united statesbuyer,they trade on 2021-11-22
25.00%
>
+View All
Products
Total 7
ProductsTransactionsPerDetail
jaka 1885.71%>
bat 314.29%>
ivermactin 314.29%>
vit 29.52%>
product name 14.76%>
+View All
Hscode rank
Total 6
HSCode NameTransactionsPerDetail
HS 3004909921100%>
Trading Area
Total 6
AreaTransactionsPerDetail
trinidad and tobago2255.00%>
united states615.00%>
lebanon410.00%>
spain410.00%>
canada25.00%>
+View All
medihome pharma is india Supplier,
and primarily engages in the import and export business of products such as jaka,bat,ivermactin.
According to the 52wmb.com global trade database, as of 2025-09-24, the company has completed 40 international trades,
with its main trading regions covering trinidad and tobago,united states,lebanon etc.
The core products include HS30049099 etc,
and its main trading partners are anne samlalsingh (mohanda suralkar),aleem ali,donovan cleary kassouf.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on medihome pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.